Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The recent change in version v2.9.0 of the webpage now includes publications from PubMed related to the study, specifically focusing on the trial of Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028), providing additional scientific and medical articles for users to access.
    Difference
    9%
    Check dated 2024-06-21T03:39:07.000Z thumbnail image
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    7 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:28:26.000Z thumbnail image
  6. Check
    15 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating an increase in the total number of patients enrolled in the study of pembrolizumab for advanced sarcomas. The expansion portion of the study will now include an additional 30 patients with undifferentiated pleomorphic sarcoma (UPS) and 30 patients with dedifferentiated or other high-grade liposarcoma (LPS).
    Difference
    0.1%
    Check dated 2024-06-06T14:18:36.000Z thumbnail image
  7. Check
    29 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    39%
    Check dated 2024-05-22T20:56:56.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:56:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.